Dacarbazine and Carmustine in Metastatic Melanoma

NCT01692691 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped PI decision

Conditions

Melanoma Metastatic

Interventions

DRUG: Dacarbazine
DRUG: Carmustine
DRUG: Neulasta

Sponsor

Western Regional Medical Center